Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Befotertinib by InventisBio for Lung Adenocarcinoma: Likelihood of Approval
Befotertinib is under clinical development by InventisBio and currently in Phase II for Lung Adenocarcinoma. According to GlobalData, Phase II...